Call Today: 800-889-3898
Submit your Raptiva claim details for a free, no obligation case review
Get Started:
Raptiva medication and dosing information is available from a patient's prescribing physician, or from the packaging information that comes with Raptiva. However, a patient can never be too careful or too knowledgeable about Raptiva medication and dosing, because this is a drug that has been linked to a very serious and potentially fatal side effect — progressive multifocal leukoencephalopathy (PML).
Raptiva is a psoriasis medication administered as a subcutaneous injection once a week, with the following specific dosing regimen as a guide:
The initial dosing at a lower amount is intended to minimize the risk of an allergic reaction or other Raptiva side effects. Other immunosuppressant drugs that a patient is taking may interact with Raptiva, and the administration of Raptiva should be considered in light of the patient's entire medication regimen.
Patients who experience any adverse effects of Raptiva should contact their doctor immediately. Such symptoms include:
Raptiva medication comes in a powder form that is to be mixed inside the syringe supplied for injection. Raptiva injections are given under the skin of the:
The prepared dose of Raptiva should be used right away. If for some reason the Raptiva cannot be injected immediately, it can stay safe for a number of hours at room temperature. If a patient misses his or her weekly dosing of Raptiva, the prescribing doctor should be contacted for further medication instructions.
In fact, if a patient has any questions about the dosing of Raptiva or the method of injection, he or she should contact the prescribing doctor rather than guessing or estimating the dose. As an immunosuppressant drug, an overdose or incorrect dose of Raptiva could do grave harm to a patient. Raptiva is an effective psoriasis treatment, however several patients have developed serious Raptiva infections, including life-threatening PML.
If you have suffered from adverse side effects of Raptiva, it is in your best interest to talk to an attorney who represents individuals harmed by dangerous drugs. You have legal rights and options and may qualify to recover compensation for your losses. To schedule a private, free consultation with an experienced Raptiva attorney in your area, please contact us today.
The U.S. Food and Drug Administration (FDA) announced a voluntary Raptiva recall, April 8, 2009. The Psoriasis drug’s manufacturer, Genentech, announced the voluntary Raptiva recall and has begun phasing the drug off the U.S. market. R...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice